US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist
  • 2.540
  • -0.030-1.17%
Close Nov 27 16:00 ET
  • 2.490
  • -0.050-1.96%
Post 19:39 ET
500.47MMarket Cap-3791P/E (TTM)

About Esperion Therapeutics Company

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Company Profile

SymbolESPR
Company NameEsperion Therapeutics
Listing DateJun 26, 2013
Issue Price14.00
Founded1998
CEOMr. Sheldon L. Koenig
MarketNASDAQ
Employees240
Fiscal Year Ends12-31
Address3891 Ranchero Drive,Suite 150
CityAnn Arbor
ProvinceMichigan
CountryUnited States of America
Zip Code48108
Phone1-734-887-3903
Websitehttp://www.esperion.com

Company Executives

  • Name
  • Position
  • Salary
  • Sheldon L. Koenig
  • Director, President and Chief Executive Officer
  • 2.97M
  • Benjamin Halladay
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Eric Warren, R.Ph.
  • Chief Commercial Officer
  • 1.08M
  • J. Martin Carroll
  • Chairman of the Board
  • 117.28K
  • Stephen C. Rocamboli
  • Independent Director
  • 94.78K
  • Seth H.Z. Fischer
  • Independent Director
  • 99.78K
  • Jay P. Shepard
  • Independent Director
  • 97.28K
  • Dr. Antonio M. Gotto,Jr,M.D.,D.Phil.
  • Independent Director
  • 82.28K
  • Tracy M. Woody
  • Independent Director
  • 91.97K
  • Alan Fuhrman
  • Independent Director
  • 104.78K
  • Nicole Vitullo
  • Independent Director
  • 94.78K
  • Benjamin O. Looker
  • General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data